
SNMMI 2021 Presentations
19 accepted works by our team and collaborators (5 oral; 14 posters) are being presented at the 2021 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (June 11-15):
19 accepted works by our team and collaborators (5 oral; 14 posters) are being presented at the 2021 Annual Meeting of the Society of Nuclear Medicine & Molecular Imaging (June 11-15):
Our Qurit team has partnered with artificial intelligence (AI) experts at Microsoft’s “AI for Health” program, to move towards the next generation of cancer imaging and assessment. Read more about this exciting work!
First post in a series of posts written by members of the Qurit Team. Written by Cariad Knight.
Presentation by our fantastic co-op student, Roberto Fedrigo, to the UBC Multidisciplinary Undergraduate Research Conference (MURC), with title, “Phantom-guided optimization of prostate cancer PET imaging using radioactive epoxy lesions”:
Congratulations to Roberto Fedrigo who has been awarded the 2020 Summer Undergraduate Fellowship by the American Association of Physicists in Medicine (AAPM).
We welcome Mohammad Salmanpour, who has been working with us closely since 2017 (from Tehran Polytechnic), now staying with us as exchange PhD student. Mohammad focuses on improved prediction of outcome in Parkinson’s disease (PD) using machine learning algorithms.
Here is video of grand rounds lecture by Dr.
We actively recruit talented MSc and PhD students from the University of British Columbia Physics, Interdisciplinary Oncology Program, Biomedical Engineering, and Electrical & Computer Engineering.
Today we bid farewell to the incredible Wenbing Lyu, visiting PhD student for the past year from Southern Medical University, Guangzhu, China. Wenbing has led significant efforts towards robust radiomics analyses, including PET-CT “fusion radiomics”, for prediction of outcome in head & neck cancer patients.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.